No Data
Trending Industry Today: CHINASOFT INT'L Leads Gains In Saas Stocks
A Piece Of The Puzzle Missing From ClouDr Group Limited's (HKG:9955) 101% Share Price Climb
ClouDr's Digital Diabetes Product Gets Approval in China
ClouDr Group Launches AI-Driven Diabetes Drug
China Smart Healthcare (09955.HK): The diabetes digital therapeutic product ClouDT-01 has obtained the registration certificate for medical instruments in China.
Grond Hui September 26th, Zhiyun Health (09955.HK) announced that the company's independently developed diabetes digital pharmaceutical product ClouDT-01 has recently been approved by the Zhejiang Provincial Pharmaceutical Supervision and Administration Commission in China, and has obtained a medical instrument registration certificate issued by them (Zhejiang Medical Device Registration No. 20242211785). The announcement stated that ClouDT-01 is an important product in the group's digital pharmaceutical research and development pipeline. With the company's advanced artificial intelligence large model, comprehensive diabetes service management database, and rich clinical experience in diabetes, this product uses chain technology to deeply analyze the diagnosis and treatment of diabetes.
Express News | ClouDr Group - Cloudt-01 Approved by Zhejiang Medical Products Administration of China
No Data
No Data